Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Paul Rennie Insider Profile
4 Followers
Paul Rennie, Chairman & Managing Director at Paradigm Biopharmaceuticals Ltd., holds 20.73M shares in Paradigm Biopharmaceuticals Ltd. (Ticker: PBIGF), holds 1.09M shares in Neuroscientific Biopharmaceuticals Ltd. (Ticker: AU:NSB).
Paul Rennie Paradigm Biopharmaceuticals Ltd. (PBIGF)Chairman & Managing Director
Paradigm Biopharmaceuticals Ltd. (PBIGF)
Chairman & Managing Director
Ranked #95,008 out of 99,335 Corporate Insiders
Profitable Transactions
2 out of 13 Profitable Transactions
Average Return
-40.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Paul Rennie holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 09, 2022 - Mar 09, 2023
Return:+20.20%
The most profitable trade made by Paul Rennie
Paul Rennie's Trading History
Paradigm Biopharmaceuticals Ltd.
Nov 21, 2024
Chairman & Managing Director
Uninformative Sell
―
$4.41M
Neuroscientific Biopharmaceuticals Ltd.
Jun 07, 2023
Chairman & Interim Chief Executive
Informative Buy
23.99K
AU$40.36K
List of latest transactions for each holding click on a transaction to see Paul Rennie's performance on stock
You May Also Like
Paul Rennie insider profile FAQ
What is the percentage of profitable transactions made by Paul Rennie?
The percentage of profitable transactions made by Paul Rennie is 15%.
What is the average return per transaction made by Paul Rennie?
The average return per transaction made by Paul Rennie is -40.50%.
What stocks does Paul Rennie hold?
Paul Rennie holds: PBIGF, AU:NSB stocks.
What was Paul Rennie’s latest transaction?
Paul Rennie latest transaction was an Uninformative Sell of ―.
What was Paul Rennie's most profitable transaction?
Paul Rennie’s most profitable transaction was an Informative Buy of PBIGF stock on March 9, 2022. The return on the trade was 20.20%.
What is Paul Rennie's role in Paradigm Biopharmaceuticals Ltd.?
Paul Rennie's role in Paradigm Biopharmaceuticals Ltd. is Chairman & Managing Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.